Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists
CA 2439852 A1 · Owner: Dingivan, Christine · Inventors: Wilder, Ronald; Dingivan, Christine
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides to methods of preventing treating or , ameliorating one or more symptoms associated with an autoimmune or inflammatory disorder utilizing combinatorial therapy. In particular the , present invention provides methods of preventing treating, or ameliorating , one or more symptoms associated with an autoimmune or inflammatory disorder comprising administering to a subject in need thereof one or more integrin .alpha.V.beta.3 antagonists and at least one other prophylactic or therapeutic agent. The present invention also provides compositions and articles of manufacture for use in preventing, treating or ameliorating one or more symptoms associated with an …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 4, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 4, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 4, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.